Drugs for the Heart
Lionel H. Opie, Bernard J. Gersh
Elsevier Saunders, 2005 - Medical - 437 pages
The new 6th Edition continues to be the definitive pocket-sized guide on the "hows" and "whys" of cardiovascular drugs. It provides in-depth information on all of the drug classes used to treat heart disease, and covers drug use, new drug classes, drug use for single and multiple problem management, and more. A user-friendly organization speed readers to the information they need, and dynamic new full-color drawings illustrate key pharmacological and physiological actions. The new edition includes access to the companion website, which offers bi-annual content updates to keep you current with new drugs, indications and leading trials. The website also has the feature of fully searchable text to access book content via drug, disease or drug action.
What people are saying - Write a review
We haven't found any reviews in the usual places.
ACE inhibitors activity acute myocardial infarction adrenergic agents aldosterone amiodarone amlodipine angiotensin angiotensin-II antiarrhythmic antihypertensive arrhythmias aspirin atenolol atrial fibrillation benefit blockers blood pressure calcium channel captopril cardiac cardiovascular carvedilol CCBs cholesterol chronic heart failure Circulation clinical Coll Cardiol combination congestive heart failure contraindicated coronary artery disease decreased DHPs diabetes digoxin diltiazem diuresis dopamine dose drug dysfunction efficacy elderly enalapril Engl enzyme eplerenone furosemide heart disease hemodynamic heparin hydrochlorothiazide hypertension hypokalemia hypotension increased inhibition inhibitors or ARBs inotropic interactions intravenous ischemia ischemic Lancet left ventricular levels LH Opie lipid long-acting long-term loop diuretics losartan low-dose major metabolic metoprolol mg daily mortality myocardial infarction nephropathy nifedipine nitrates oral outcome P-blockade P-blockers package insert patients peripheral postinfarct potassium propranolol pulmonary ramipril receptor reduced serum side effects sinus sodium spironolactone statins stenosis syndrome systolic tachycardia therapy thiazide tion tolerance treatment trial unstable angina vascular vasodilation vasodilatory verapamil